Kara E. Geisel

Array ( [id] => 1602833 [patent_doc_number] => 06433012 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Method for inhibiting inflammatory disease' [patent_app_type] => B1 [patent_app_number] => 09/656144 [patent_app_country] => US [patent_app_date] => 2000-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 15305 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/433/06433012.pdf [firstpage_image] =>[orig_patent_app_number] => 09656144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450874 [patent_doc_number] => 06455588 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Compositions including modafinil for treatment of eating disorders and for appetite stimulation' [patent_app_type] => B1 [patent_app_number] => 09/640824 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3818 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455588.pdf [firstpage_image] =>[orig_patent_app_number] => 09640824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383614 [patent_doc_number] => 06551993 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Partial agonists at the glycine modulatory site of the NMDA receptor for treating cognitive dysfunction' [patent_app_type] => B1 [patent_app_number] => 09/639611 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4708 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551993.pdf [firstpage_image] =>[orig_patent_app_number] => 09639611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507990 [patent_doc_number] => 06440999 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Intimal thickening inhibitory agent' [patent_app_type] => B1 [patent_app_number] => 09/637022 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6376 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440999.pdf [firstpage_image] =>[orig_patent_app_number] => 09637022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531270 [patent_doc_number] => 07175833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-13 [patent_title] => 'Glass composition' [patent_app_type] => utility [patent_app_number] => 10/069143 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8985 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/175/07175833.pdf [firstpage_image] =>[orig_patent_app_number] => 10069143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586044 [patent_doc_number] => 06358944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Methods and compositions for treating generalized anxiety disorder' [patent_app_type] => B1 [patent_app_number] => 09/638058 [patent_app_country] => US [patent_app_date] => 2000-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3779 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358944.pdf [firstpage_image] =>[orig_patent_app_number] => 09638058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410159 [patent_doc_number] => 06300356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 9/601938 [patent_app_country] => US [patent_app_date] => 2000-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 10105 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300356.pdf [firstpage_image] =>[orig_patent_app_number] => 601938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523971 [patent_doc_number] => 06352984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Olanzapine-N-oxide compositions and methods' [patent_app_type] => B1 [patent_app_number] => 09/632584 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3176 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352984.pdf [firstpage_image] =>[orig_patent_app_number] => 09632584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634161 [patent_doc_number] => 07129218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration' [patent_app_type] => utility [patent_app_number] => 10/048923 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8758 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129218.pdf [firstpage_image] =>[orig_patent_app_number] => 10048923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340894 [patent_doc_number] => 06589944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Breakers of advanced glycation endproducts' [patent_app_type] => B1 [patent_app_number] => 09/626859 [patent_app_country] => US [patent_app_date] => 2000-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7569 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589944.pdf [firstpage_image] =>[orig_patent_app_number] => 09626859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560157 [patent_doc_number] => 06436913 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Use of estramustine phosphate in the treatment of bone metastasis' [patent_app_type] => B1 [patent_app_number] => 09/625540 [patent_app_country] => US [patent_app_date] => 2000-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2349 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436913.pdf [firstpage_image] =>[orig_patent_app_number] => 09625540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595132 [patent_doc_number] => 06384020 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Rapid immediate release oral dosage form' [patent_app_type] => B1 [patent_app_number] => 09/611098 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2490 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384020.pdf [firstpage_image] =>[orig_patent_app_number] => 09611098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068415 [patent_doc_number] => 06843981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Tooth bleaching compositions and methods of bleaching discolored tooth' [patent_app_type] => utility [patent_app_number] => 10/019408 [patent_app_country] => US [patent_app_date] => 2000-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4393 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/843/06843981.pdf [firstpage_image] =>[orig_patent_app_number] => 10019408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521082 [patent_doc_number] => 06413968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Treatment of myasthenia gravis by cyclic nucleotide phosphodiesterase inhibition' [patent_app_type] => B1 [patent_app_number] => 09/606818 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 808 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413968.pdf [firstpage_image] =>[orig_patent_app_number] => 09606818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454199 [patent_doc_number] => 06462089 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Method for correcting the vigilance disorders associated with myopathies' [patent_app_type] => B1 [patent_app_number] => 09/606238 [patent_app_country] => US [patent_app_date] => 2000-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1630 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462089.pdf [firstpage_image] =>[orig_patent_app_number] => 09606238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494664 [patent_doc_number] => 06342515 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Remedy for neurodegenerative diseases' [patent_app_type] => B1 [patent_app_number] => 09/582433 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3420 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342515.pdf [firstpage_image] =>[orig_patent_app_number] => 09582433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 784944 [patent_doc_number] => 06989158 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-24 [patent_title] => 'Gold-containing chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 10/019192 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4880 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989158.pdf [firstpage_image] =>[orig_patent_app_number] => 10019192 [rel_patent_id] =>[rel_patent_doc_number] =>)